News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Beetham Thomas W.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/02/2022 |
4
| Beetham Thomas W. (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 3,000 shares
@ $0.94, valued at
$2.8k
|
|
| 08/01/2022 |
4
| Beetham Thomas W. (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $1.57, valued at
$117.8k
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Beetham Thomas W. (See Remarks) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $3.19, valued at
$239.3k
|
|
| 09/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Converted 300,000 shares
@ $0
Sold 2,477 shares
@ $22.09, valued at
$54.7k
Converted 300,000 options to buy
@ $0 |
|
| 09/14/2020 |
4
| Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 75,000 options to buy
@ $15.5, valued at
$1.2M
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Sold 13,752 shares
@ $25.07, valued at
$344.8k
Exercised 13,752 options to buy
@ $1.59, valued at
$21.9k
|
|
| 04/22/2020 |
4
| Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Sold 47,423 shares
@ $19.06, valued at
$903.9k
Sold 1,563 shares
@ $19.56, valued at
$30.6k
Sold 955 shares
@ $20.44, valued at
$19.5k
|
|
| 03/17/2020 |
4
| Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 75,000 options to buy
@ $15.52, valued at
$1.2M
|
|
| 02/19/2020 |
4
| Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Sold 59 shares
@ $18.58, valued at
$1.1k
|
|
| 09/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2019 |
4
| Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 42,000 options to buy
@ $17.92, valued at
$752.6k
|
|
| 09/24/2018 |
4
| Beetham Thomas W. (EVP & Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 45,000 options to buy
@ $30.93, valued at
$1.4M
|
|
| 05/29/2018 |
4
| Beetham Thomas W. (Chief Legal Officer) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Converted 6,392 shares
@ $0
Bought 6,392 options to buy
@ $15.6438, valued at
$100k
Converted 48,172 options to buy
@ $0
Converted 6,392 options to buy
@ $0 |
|
|
|